Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Koninklijke Philips (RYLPF) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Koninklijke Philips (RYLPF) over the last 17 years, with Q3 2025 value amounting to $2.2 billion.

  • Koninklijke Philips' Cash & Equivalents rose 889.91% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 billion, marking a year-over-year increase of 889.91%. This contributed to the annual value of $2.6 billion for FY2024, which is 2758.75% up from last year.
  • Latest data reveals that Koninklijke Philips reported Cash & Equivalents of $2.2 billion as of Q3 2025, which was up 889.91% from $2.1 billion recorded in Q2 2025.
  • Over the past 5 years, Koninklijke Philips' Cash & Equivalents peaked at $4.5 billion during Q3 2021, and registered a low of $1.2 billion during Q4 2022.
  • Over the past 5 years, Koninklijke Philips' median Cash & Equivalents value was $2.1 billion (recorded in 2024), while the average stood at $2.2 billion.
  • In the last 5 years, Koninklijke Philips' Cash & Equivalents skyrocketed by 14751.71% in 2021 and then plummeted by 7189.52% in 2022.
  • Quarter analysis of 5 years shows Koninklijke Philips' Cash & Equivalents stood at $2.6 billion in 2021, then plummeted by 54.61% to $1.2 billion in 2022, then surged by 68.18% to $2.0 billion in 2023, then rose by 27.59% to $2.6 billion in 2024, then fell by 12.88% to $2.2 billion in 2025.
  • Its Cash & Equivalents stands at $2.2 billion for Q3 2025, versus $2.1 billion for Q2 2025 and $1.3 billion for Q1 2025.